BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 5, 2016
View Archived Issues
Scientists identify methylated regions associated with hand osteoarthritis
Read More
Cellectar Biosciences reports updated results from phase I study of CLR-131
Read More
Signature Therapeutics initiates phase I study of PF-614
Read More
Bristol-Myers Squibb initiates phase I/IIa study of BMS-986207
Read More
ACADIA Pharmaceuticals initiates phase II trial of pimavanserin for adjunctive therapy for MDD
Read More
GSK files MAA for once-daily closed triple combination therapy for patients with COPD
Read More
Novel CDC7 inhibitor TAK-931 demonstrates potent antitumor activity in vitro and in vivo
Read More
AiCuris begins phase II study of pritelivir
Read More
FDA accepts for review sBLA for Keytruda in classical Hodgkin's lymphoma
Read More
DiaMedica sells DM-71 and related IP
Read More
Opdivo approved in Japan for relapsed or refractory classical Hodgkin's lymphoma
Read More
First-in-human data reported for checkpoint inhibitor TTI-62 at ASH
Read More
Mochida obtains Japanese approval for Dinagest for adenomyosis
Read More
English NICE recommends use of pembrolizumab for advanced NSCLC
Read More
EMA committee confirms hepatitis B re-activation risk with direct-acting antivirals for hepatitis C
Read More
Kite Pharma initiates rolling BLA submission for KTE-C19
Read More
Merck & Co. to advance anti-CD27 agonist from Aduro collaboration
Read More
Amryt Pharma in-licenses European and Middle Eastern rights to Lojuxta
Read More
Phase III study of Shire's Vonvendi meets primary endpoint
Read More
Acetylon enters agreement to be acquired by Celgene, plans to launch spin-out
Read More
ReNeuron reports data from phase II trial of CTX cell therapy candidate for stroke disability
Read More
Preliminary phase I data from ZUMA-3 and ZUMA-4 studies of KTE-C19 presented
Read More
Cannabidivarin receives orphan designation for Rett syndrome in the U.S.
Read More
The Center Translational Drug Development patents novel Rho kinase inhibitors
Read More
Sun Pharma Advanced Research patents new tyrosine kinase inhibitors
Read More
Merck & Co. presents novel phosphodiesterase PDE2A inhibitors
Read More
Roche identifies new survival motor neuron protein 2 splicing modulators
Read More
Lilly patents novel DGAT-2 inhibitors
Read More
FDA approves new indication for Jardiance
Read More
Imbruvica approved for new indication in Japan
Read More
Cellular Biomedicine cleared in China to start phase I study of C-CAR-011
Read More